EVOFEM BIOSCIENCES, INC.

Analyst Reco. Evofem Biosciences, Inc.

Equities

EVFM

US30048L3024

Market Closed - OTC Markets Other stock markets 03:55:21 2024-04-25 pm EDT			5-day change	1st Jan Change
0.0142 ^USD	-4.70%		+0.71%	-77.81%

Mar. 27	Evofem Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 27	Evofem Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Laidlaw Downgrades Evofem Biosciences to Hold From Buy	Dec. 13	MT
Stifel Downgrades Evofem Biosciences to Hold From Buy, Adjusts Price Target to $0.50 From $3	22-10-13	MT
HC Wainwright Adjusts Price Target on Evofem Biosciences to $4 From $2, Reiterates Buy Rating	22-08-15	MT
Morgan Stanley Adjusts Price Target for Evofem Biosciences to $0.75 From $2, Maintains Underweight Rating	22-07-14	MT
Laidlaw & Co. Initiates Evofem Biosciences at Buy with $3.50 Price Target	22-06-02	MT
Piper Sandler Adjusts Price Target on Evofem Biosciences to $2 From $30, Reiterates Overweight Rating	22-05-25	MT
Wall Street Set for Gains as China Rate Cut Boosts Sentiment	22-05-20	MT
Morgan Stanley Lowers Evofem Biosciences Price Target to $2 From $8.55, Maintains Underweight Rating	22-05-11	MT
EVOFEM BIOSCIENCES : HC Wainwright Adjusts Evofem Biosciences' Price Target to $2.50 from $4, Keeps Buy Rating	21-10-21	MT
EVOFEM BIOSCIENCES : Morgan Stanley Downgrades Evofem Biosciences to Underweight Rating From Equal-Weight, Lowers PT to $0.80 From $1	21-10-14	MT
EVOFEM BIOSCIENCES : Morgan Stanley Adjusts Price Target on Evofem Biosciences to $1 From $3, Maintains Equal-Weight Rating	21-08-12	MT
EVOFEM BIOSCIENCES : HC Wainwright Adjusts Price Target on Evofem Biosciences to $4 From $7, Maintains Buy Rating	21-06-07	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer